Has Brandon Maceyko, OD received payments from drug or device companies?

Yes. Drug and device makers reported $9,297 in general payments to Brandon Maceyko, OD across 141 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brandon Maceyko, OD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brandon Maceyko, OD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brandon Maceyko, OD

Optometrist · Boardman, OHNPI 1649837964

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,207 of the $9,297 with a category attached, or 66.8%. 17 manufacturers reported payments, led by Alcon at 32.1% of the total. 2025 is the largest year on record at $2,722, more than ten times the $254 reported in 2019. Among optometrist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,297in general payments, 2019–2025

Across 141 payments — averaging $65.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$3K
Johnson & Johnson Vision Care, Inc.$2K
Coopervision Inc.$2K
Bausch & Lomb Americas Inc.$1K
Biotissue Holdings Inc.$246
Bausch & Lomb, A Division Of Bausch Health US, LLC$131
plus $852 from 11 others

What the payments were for

Travel & lodging$3,06533%
Food & beverage$6,20767%
Entertainment$240%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	48	$2,985
Johnson & Johnson Vision Care, Inc.	29	$1,934
Coopervision Inc.	20	$1,837
Bausch & Lomb Americas Inc.	24	$1,312
Biotissue Holdings Inc.	2	$246
Bausch & Lomb, A Division Of Bausch Health US, LLC	2	$131
AbbVie	1	$123
Oyster Point Pharma, Inc.	2	$118
Dompe US, Inc.	2	$117
Kala Pharmaceuticals, Inc.	1	$97
Tarsus Pharmaceuticals, Inc.	2	$94
Lombart Brothers, Inc.	1	$89
Optos, Inc.	2	$67
ABB Con-cise Optical Group LLC	1	$56
Visioneering Technologies, Inc.	2	$43
Amgen	1	$29
Novartis	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,297 in reported general payments places this provider in the 95th percentile of 1,995 optometrist providers in Ohio.

See all optometrist providers in Ohio →

Medicare billing

Part B allowed, 2024

$14,502

Medicare patients

Services billed

147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Latanoprost	25	$246
Timolol Maleate	14	$158

Paid to pharmacies, not to this prescriber.

Other optometrist in Boardman

Ryan MaceykoBoardman$10K
Mile BrujicBowling Green$1.3M
Gregory DenaeyerColumbus$846K
Cory LappinMontgomery$367K
Chris SmileyColumbus$305K
Thomas ChesterCleveland$300K
Carly RoseCincinnati$203K
Wendy HallierReynoldsburg$200K
John LahrCincinnati$145K
Erin RueffColumbus$131K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →